Trials / Completed
CompletedNCT04599959
COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR
COVID-19 Tests: a Systematic Comparison of Viral RNA Test Sample Taking for RT-qPCR, in This Case With a Nasopharyngeal Swab or Saliva Collected With Salivette® Cortisol, to Diagnose SARS-CoV-2 Virus Infection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the tests is to establish saliva collection with Salivette® Cortisol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol | Kylt® for detection/confirmation of SARS-CoV-2 cobas® SARS-CoV-2 (PCR) test TaqPath™ COVID-19 CE-IVD RT-PCR kit |
Timeline
- Start date
- 2020-10-26
- Primary completion
- 2021-01-20
- Completion
- 2021-01-20
- First posted
- 2020-10-23
- Last updated
- 2021-07-26
- Results posted
- 2021-07-26
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04599959. Inclusion in this directory is not an endorsement.